Jobs by Specialisation
Oligonucleotide Therapeutics
Jobs
No openings found right now · Updated daily
Open Roles
0
Avg Salary
$159k
Remote-Friendly
36%
Added This Week
2
Sectors with Oligonucleotide Therapeutics Roles
11 of 0 positions Updated daily
Business Development Manager - CDMO - Therapeutics/Life Science (m/f/x)
LGC Group
Berlin, BE, Germany Remote mid Direct
Senior Principal Scientist – DMPK Project Representative
Bristol Myers Squibb
United States of America Hybrid Senior Direct
Automation Project Engineer
The Specific Pay Range For A Preferred Location
US-CO-Boulder Onsite Direct
Principal Automation Engineer
Agilent Technologies
US-CO-Frederick Onsite Principal Direct
Oligo Discovery Chemistry Principal Scientist
GSK
United States of America Onsite Senior Direct
Alliance Manager
Inceptive
Palo Alto, California, United States Onsite Senior Direct
Project Coordinator II
Arrowhead Pharmaceuticals
Madison, Wisconsin, United States Onsite Direct
Executive Director, Development Sciences
Novartis
LaJolla/SD Hybrid Director Direct
Principal Scientist II/Senior Principal Scientist, Modeling & Simulation (Dual Level Posting)
Novartis
United States of America Hybrid Senior Direct
Executive Director, Development Sciences
Novartis
LaJolla/SD Hybrid Director Direct
Associate Director / Director, Toxicology
Korro
60 First St, Cambridge, MA 02141 Director Direct
Common Questions
- How many Oligonucleotide Therapeutics jobs are available?
- JobsGlitch lists active Oligonucleotide Therapeutics jobs sourced daily from Greenhouse, Lever, Ashby, Workday, and other top ATS platforms.
- Where are most Oligonucleotide Therapeutics jobs located?
- Oligonucleotide Therapeutics jobs are available globally — including remote positions.
- Are there remote Oligonucleotide Therapeutics jobs?
- Yes — 36% of current Oligonucleotide Therapeutics job listings are remote-friendly.
- Which companies are hiring for Oligonucleotide Therapeutics roles?
- Top companies currently hiring in Oligonucleotide Therapeutics include Novartis, LGC Group, Bristol Myers Squibb.